Rybelsus: A Breakthrough in Diabetes Management and Heart Health Business March 29, 2025 Novo Nordisk’s diabetic tablet, Libers, has shown promising cardiovascular benefits in late-stage trials, according to results presented at the American…
Breakthrough Treatments Approved for Hemophilia A and B Management Business March 28, 2025 On March 28, 2025, the US Food and Drug Administration (FDA) approved Qfitlia (Fitusiran) for the prevention and reduction of…
